Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Mild Cognitive Impairment
NEJM 362:2227-2234, Peterson, R.C., 2011
Pediatric Moyamoya Disease: An Analysis of 410 Consecutive Cases
Ann Neurol 68:92-101, Kim,S.-K., et al, 2010
Anti-Ma and Anti-Ta Associated Paraneoplastic Neurological Syndromes: 22 Newly Diagnosed Patients and Review of Previous Cases
JNNP 79:767-773,742, Hoffmann,L.A.,et al, 2008
A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
The role of radiotracer imaging in Parkinson disease
Neurol 64:208-215, Ravina, B., et al, 2005
A New Cause of Limbic Encephalopathy
Brain 128:1745-1746, Darnell,R.B., et al, 2005
Neuroprotection in Parkinson Disease, Mysteries, Myths, and Misconceptions
JAMA 291:358-364, Schapira,A.H.V.&Olanow,C.W., 2004
Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003
Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
PET with 18 Fluorodeoxyglucose and Hexamethylpropylene Amine Oxime SPECT in Late Whiplash Syndrome
Neurol 51:345-350, 3361998., Bicik,I.,et al, 1998
Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998
Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997
Neuroimaging Findings in Patients with AIDS
Clin Inf Dis 22:906-919, Walot,I.,et al, 1996
Imaging the Head:Functional Imaging
JNNP 58:132-144, Sawle,G.V., 1995
New Anatomical and Functional Imaging Methods
Ann Neurol 32:395-400, Prichard,J.W.&Brass,L.M., 1992
Advances in Neurology
NEJM 326:1608-1616, 1671-16761992., Gilman,S., 1992
The Biology of Developmental Dyslexia
JAMA 268:912-915, Rumsey,J.M., 1992
HIV Encephalopathy and Dementia
Psychiatr Clin North Am 15:455-466, Pajeau,A.K.&Roman,G.C., 1992
Assessment:Positron Emission Tomography
Report of Therapeutics & Technology Assessment Subcommittee of the AAN, Neurol 41:163-16791., , 1991
PET:Its Clinical Role in Neurology
JNNP 54:1-5, Brooks,D.J., 1991
Preclinical Detection of Parkinson's Disease
Neurology Suppl 2, 41:5-921991., Koller,W.C.&Langston,J.W., 1991
Technology Assessment Revisited:Does Positron Emission Tomography Have Proven Clinical Efficacy?
Neurol 41:1339-1340, Powers,W.J.,et al, 1991
National Cancer Institute Workshop Statement
Advances in Clinical Imaging Using Positron Emission Tomography, Arch Int Med 150:735-739, 729990., , 1990
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
PET Scanning, Provides Information on Function
BMJ 298:692-694, Frackowiak,R.S.J.&Jones,T., 1989
Diagnosis & Treatment of Aphasia, Part I & Part II
JAMA 259:1043-1047, 1205-12101988., Albert,M.L.&Helm-Estabrooks,N., 1988
Positron Emission Tomography-A New Approach to Brain Chemistry
JAMA 260:2704-2710, Jacobson,H.G., 1988
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986